These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2094053

  • 1. Use of a new erythromycin product--eryc--in the treatment of the lower respiratory tract infections.
    Adám A, Kuberka Z.
    Ther Hung; 1990; 38(4):152-5. PubMed ID: 2094053
    [Abstract] [Full Text] [Related]

  • 2. Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycin.
    Peugeot RL, Lipsky BA, Hooton TM, Pecoraro RE.
    Drugs Exp Clin Res; 1991; 17(5):253-7. PubMed ID: 1756688
    [Abstract] [Full Text] [Related]

  • 3. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B, Wilen-Rosenqvist G, Lehtonen L.
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [Abstract] [Full Text] [Related]

  • 4. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
    Stocks JM, Wallace RJ, Griffith DE, Garcia JG, Kohler RB.
    Am J Med; 1989 Dec 29; 87(6C):52S-56S. PubMed ID: 2690620
    [Abstract] [Full Text] [Related]

  • 5. [Netilmicin in the treatment of bacterial respiratory tract infections].
    Wandzilak M, Głuszko P, Królikowski W, Prokop A, Soja J, Szczeklik A.
    Pol Tyg Lek; 1989 Dec 29; 45(36-37):749-51. PubMed ID: 2084631
    [Abstract] [Full Text] [Related]

  • 6. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
    Schouten JA, Hulscher ME, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RP, van der Meer JW.
    Clin Infect Dis; 2007 Apr 01; 44(7):931-41. PubMed ID: 17342644
    [Abstract] [Full Text] [Related]

  • 7. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO, Ohaju-Obodo J.
    West Afr J Med; 1996 Apr 01; 15(2):111-6. PubMed ID: 8855675
    [Abstract] [Full Text] [Related]

  • 8. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT, Awad CE, Ali A, Matyas R, Vital AC, Silva CO, Dainesi SM, Salazar MS, Nakatani J.
    Int J Clin Pract; 1999 Sep 01; 53(6):433-6. PubMed ID: 10622070
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of twice-daily amoxycillin/clavulanate in lower respiratory tract infections.
    Balgos AA, Rodriguez-Gomez G, Nasnas R, Mahasur AA, Margono BP, Tinoco-Favila JC, Sansores-Martinez RH, Hassan M, Beppo O, Wongsa A, Cukier A, Vargas F.
    Int J Clin Pract; 1999 Sep 01; 53(5):325-30. PubMed ID: 10695094
    [Abstract] [Full Text] [Related]

  • 10. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia.
    Wu JH, Howard DH, McGowan JE, Frau LM, Dai WS.
    Clin Ther; 2004 Dec 01; 26(12):2153-62. PubMed ID: 15823779
    [Abstract] [Full Text] [Related]

  • 11. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE, Schlossberg D, Donowitz GR, Scheld WM, Zellner SR, Lindenberg LB, Armstrong JH, Ein ME.
    Clin Ther; 1989 Dec 01; 11(3):304-14. PubMed ID: 2663160
    [Abstract] [Full Text] [Related]

  • 12. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW, Pettit KG, Arnold RJ, Kaniecki DJ.
    Am J Manag Care; 1997 Jul 01; 3(7):1027-36. PubMed ID: 10173367
    [Abstract] [Full Text] [Related]

  • 13. Overview of experience with ofloxacin in respiratory tract infection.
    Ball P.
    Scand J Infect Dis Suppl; 1990 Jul 01; 68():56-63. PubMed ID: 2218424
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of brodimoprim in respiratory tract infections.
    Moretti M, Marchioni CF, Bisetti A.
    J Chemother; 1993 Dec 01; 5(6):517-20. PubMed ID: 8195848
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M, Velluti G.
    J Chemother; 1995 Jun 01; 7 Suppl 2():137-42. PubMed ID: 8622102
    [Abstract] [Full Text] [Related]

  • 16. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW, Laforge J, Dubois J, Small D, Grossman R, Zakhari R.
    Clin Invest Med; 1995 Apr 01; 18(2):131-8. PubMed ID: 7788958
    [Abstract] [Full Text] [Related]

  • 17. [Oral and parenteral amoxicillin in the treatment of pneumonia and acute bronchitis].
    Ekoule D.
    Pharmatherapeutica; 1989 Apr 01; 5(6):387-91. PubMed ID: 2594821
    [Abstract] [Full Text] [Related]

  • 18. Treatment of lower respiratory tract infections with cefoperazone.
    Kaplowitz LG, Sarubbi FA.
    Clin Ther; 1983 Apr 01; 5(3):243-50. PubMed ID: 6221798
    [Abstract] [Full Text] [Related]

  • 19. [The compound "eric" in the treatment of bronchopulmonary diseases].
    Orlov VA, Sokolova VI, Shchenderovich VA, Solomonova SV, Ved'mina EA.
    Klin Med (Mosk); 1992 Apr 01; 70(9-10):39-41. PubMed ID: 1474809
    [Abstract] [Full Text] [Related]

  • 20. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA.
    Pediatr Pulmonol; 2003 Feb 01; 35(2):91-8. PubMed ID: 12526069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.